Top compounds associated with response to S100A13


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.03 0.5
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.5
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.029 0.5
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC -0.092 0.5
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.029 0.5
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.067 0.5
mRNA AM-580 CTRPv2 pan-cancer AAC -0.03 0.5
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.028 0.5
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.5
mRNA pifithrin-mu CTRPv2 pan-cancer AAC -0.027 0.5
Download CSV